Epocrates

epocrates
Company type	Private
Traded as	Nasdaq: EPOC
Founded	January 1, 1998; 26 years ago
Headquarters	San Mateo , United States
Revenue	$93.7 million (2009); $83.3 million (2008)
Website	www.epocrates.com

epocrates is a widely used mobile medical reference application that provides healthcare professionals with access to clinical information at the point of care. The software is designed to assist physicians, pharmacists, nurse practitioners, physician assistants and other healthcare providers in making informed decisions about drug interactions, medical calculations, diagnosis and treatment options. It was initially developed as a Palm Pilot application in 1998 and has since evolved into a comprehensive medical resource available on various platforms.

History

Founded in 1998 by three Stanford Business School students,^[2] early versions of Epocrates ran on Palm devices^[3] and desktop computers. By 2006, the user base had reached an estimated 525,000 users worldwide, including 200,000 doctors in the United States.^[4] Upon the introduction of the Apple iPhone, Epocrates became the first medical app on Apple's mobile platform.^[5]

Early funding partners [AM1] included Bay City Capital, Draper Fisher Jurvetson, Interwest Partners, Sprout Group, and Three Arch Partners.^[4]

In 2010, the company grew to more than 250 employees^[2] and surpassed 1 million users worldwide, including 40% of the physicians in the United States.^[6]

On January 7, 2013, it was announced that athenahealth would acquire Epocrates for about $293 million.^[7]

In February 2022, Matt Titus was appointed as COO.^[8]

Products

The Epocrates app is designed for physicians and other healthcare professionals for use at the point of care. App users check drug dosing, drug interactions,^[9] drug safety details, medical news, disease diagnosis and management guidance, as well as evidence-based clinical practice guidelines.^[10]

athenahealth markets free and paid subscription versions of the app, which are available from Google Play or the App Store.^[11]

References

^ "EPOCRATES, INC". SEC.gov. 2009-12-31. Archived from the original on 2023-08-23. Retrieved 2024-07-04.
^ ^a ^b "Media Room". Epocrates. Archived from the original on 2010-09-23. Retrieved 2010-09-23. ^{[verification needed]}
^ Milt Freudenheim (January 8, 2001). "Digital Doctoring; The Race Is On to Put a Computer Into Every Physician's Hand". New York Times. Archived from the original on November 13, 2016. Retrieved February 19, 2017. ^{[verification needed]}
^ ^a ^b Chris Rauber (August 18, 2006). "Epocrates putting drug info into docs' pockets". San Francisco Business Times. Archived from the original on May 1, 2012. Retrieved September 23, 2010. ^{[verification needed]}
^ Merrell, Ronald C.; Doarn, Charles R. (February 2014). "m-Health". Telemedicine and e-Health. 20 (2): 99–101. doi:10.1089/tmj.2014.9997. ISSN 1530-5627. PMC 3911767. PMID 24502195.
^ "Epocrates files to raise up to $75M in IPO". San Francisco Business Times. July 16, 2010. Archived from the original on October 11, 2010. Retrieved September 23, 2010. ^{[verification needed]}
^ Brian Dolan (January 7, 2013). "AthenaHealth buys Epocrates for $293M". MobiHealthNews. Archived from the original on February 15, 2022. Retrieved February 15, 2022.
^ "epocrates Bolsters Executive Leadership by Adding Matt Titus as Chief Commercial Officer". PharmExec. February 9, 2022. Archived from the original on February 15, 2022. Retrieved February 15, 2022.
^ Candice Novak (May 14, 2008). "Healthcare IT company is going public after partnering with Apple". US News. Archived from the original on July 10, 2012. Retrieved March 30, 2015. ^{[verification needed]}
^ WOOD, STUART F (1986). "Review of Hay Fever. 1. Historical Background and Mechanisms". Family Practice. 3 (1): 54–63. doi:10.1093/fampra/3.1.54. ISSN 0263-2136. PMID 3514346.
^ "Last Day to Get Epocrates Essentials for Free for Medical Students". Medgadget. August 31, 2010. ^{[verification needed]}

External links

Official website
- Historical business data for Epocrates Inc.:
- SEC filings

[s388-1] "EPOCRATES, INC". SEC.gov. 2009-12-31. Archived from the original on 2023-08-23. Retrieved 2024-07-04.

[:0-2] "Media Room". Epocrates. Archived from the original on 2010-09-23. Retrieved 2010-09-23. ^{[verification needed]}

[3] Milt Freudenheim (January 8, 2001). "Digital Doctoring; The Race Is On to Put a Computer Into Every Physician's Hand". New York Times. Archived from the original on November 13, 2016. Retrieved February 19, 2017. ^{[verification needed]}

[:1-4] Chris Rauber (August 18, 2006). "Epocrates putting drug info into docs' pockets". San Francisco Business Times. Archived from the original on May 1, 2012. Retrieved September 23, 2010. ^{[verification needed]}

[5] Merrell, Ronald C.; Doarn, Charles R. (February 2014). "m-Health". Telemedicine and e-Health. 20 (2): 99–101. doi:10.1089/tmj.2014.9997. ISSN 1530-5627. PMC 3911767. PMID 24502195.

[6] "Epocrates files to raise up to $75M in IPO". San Francisco Business Times. July 16, 2010. Archived from the original on October 11, 2010. Retrieved September 23, 2010. ^{[verification needed]}

[7] Brian Dolan (January 7, 2013). "AthenaHealth buys Epocrates for $293M". MobiHealthNews. Archived from the original on February 15, 2022. Retrieved February 15, 2022.

[8] "epocrates Bolsters Executive Leadership by Adding Matt Titus as Chief Commercial Officer". PharmExec. February 9, 2022. Archived from the original on February 15, 2022. Retrieved February 15, 2022.

[9] Candice Novak (May 14, 2008). "Healthcare IT company is going public after partnering with Apple". US News. Archived from the original on July 10, 2012. Retrieved March 30, 2015. ^{[verification needed]}

[10] WOOD, STUART F (1986). "Review of Hay Fever. 1. Historical Background and Mechanisms". Family Practice. 3 (1): 54–63. doi:10.1093/fampra/3.1.54. ISSN 0263-2136. PMID 3514346.

[11] "Last Day to Get Epocrates Essentials for Free for Medical Students". Medgadget. August 31, 2010. ^{[verification needed]}

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]